- Email: [email protected]
Corrigendum to: “Rapamycin protects against middle cerebral artery occlusion induced focal cerebral ischemia in rats” [Behav. Brain Res. 225 (2011) 603–609]
Behavioural Brain Research 229 (2012) 451
Contents lists available at SciVerse ScienceDirect
Behavioural Brain Research journal homepage: www.elsevier.com/locate/bbr
Corrigendum
Corrigendum to: “Rapamycin protects against middle cerebral artery occlusion induced focal cerebral ischemia in rats” [Behav. Brain Res. 225 (2011) 603–609] Anjali Chauhan a , Uma Sharma b , N.R. Jagannathan b , K.H. Reeta a , Yogendra Kumar Gupta a,∗ a b
Neuropharmacology Laboratory, Department of Pharmacology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India Department of Nuclear Magnetic Resonance, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India
The authors regret that errors were published in Table 1. The correct table is below. The authors would like to apologise for any inconvenience caused. The ADC values reported on Page no - 605, Table 1. Following are the correct values. In paragraph 2 of results section (Page no - 605, 2nd sentence and 4th sentence), 2nd and 4th sentence after replacing corrected values of ADC may now be read as following: 2nd sentence: The ADC value in the right hemisphere in the vehicle treated rats 5.4 ± 1.2 × 10−4 mm2 /s was significantly (P < 0.05) lower than the normal contralateral hemisphere 7.9 ± 1.1 × 10−4 mm2 /s. 4th sentence: One way ANOVA revealed significant difference in the ADC values of the treatment groups [F(3, 11) = 6.306, P = 0.010].
Table 1 Effect of rapamycin on the signal intensity, ADC and % infarct area in MCAo model of focal ischemia. Parameters
Vehicle
Rapamycin (50 g/kg)
Rapamycin (150 g/kg)
Rapamycin (250 g/kg)
Signal intensity (arbitrary unit) ADC (10−4 mm2 /s) % age infarct area
178748.6 ± 1842.6 5.4 ± 1.2 52.6 ± 5.6
176923.5 ± 4092.8 6.7 ± 0.9 42.8 ± 7.5
162261.4 ± 3867.2* 7.0 ± 1.2* 24.9 ± 0.9*
154212.0 ± 1391.3* 7.6 ± 1.2* 15.2 ± 1.3*
DOI of original article: 10.1016/j.bbr.2011.08.035. ∗ Corresponding author. Tel.: +91 011 26593282; fax: +91 011 26588500/26588641/26588663. E-mail addresses: [email protected] (A. Chauhan), [email protected] (Y.K. Gupta). 0166-4328/$ – see front matter © 2012 Elsevier B.V. All rights reserved. doi:10.1016/j.bbr.2012.01.005
Contents lists available at SciVerse ScienceDirect
Behavioural Brain Research journal homepage: www.elsevier.com/locate/bbr
Corrigendum
Corrigendum to: “Rapamycin protects against middle cerebral artery occlusion induced focal cerebral ischemia in rats” [Behav. Brain Res. 225 (2011) 603–609] Anjali Chauhan a , Uma Sharma b , N.R. Jagannathan b , K.H. Reeta a , Yogendra Kumar Gupta a,∗ a b
Neuropharmacology Laboratory, Department of Pharmacology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India Department of Nuclear Magnetic Resonance, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India
The authors regret that errors were published in Table 1. The correct table is below. The authors would like to apologise for any inconvenience caused. The ADC values reported on Page no - 605, Table 1. Following are the correct values. In paragraph 2 of results section (Page no - 605, 2nd sentence and 4th sentence), 2nd and 4th sentence after replacing corrected values of ADC may now be read as following: 2nd sentence: The ADC value in the right hemisphere in the vehicle treated rats 5.4 ± 1.2 × 10−4 mm2 /s was significantly (P < 0.05) lower than the normal contralateral hemisphere 7.9 ± 1.1 × 10−4 mm2 /s. 4th sentence: One way ANOVA revealed significant difference in the ADC values of the treatment groups [F(3, 11) = 6.306, P = 0.010].
Table 1 Effect of rapamycin on the signal intensity, ADC and % infarct area in MCAo model of focal ischemia. Parameters
Vehicle
Rapamycin (50 g/kg)
Rapamycin (150 g/kg)
Rapamycin (250 g/kg)
Signal intensity (arbitrary unit) ADC (10−4 mm2 /s) % age infarct area
178748.6 ± 1842.6 5.4 ± 1.2 52.6 ± 5.6
176923.5 ± 4092.8 6.7 ± 0.9 42.8 ± 7.5
162261.4 ± 3867.2* 7.0 ± 1.2* 24.9 ± 0.9*
154212.0 ± 1391.3* 7.6 ± 1.2* 15.2 ± 1.3*
DOI of original article: 10.1016/j.bbr.2011.08.035. ∗ Corresponding author. Tel.: +91 011 26593282; fax: +91 011 26588500/26588641/26588663. E-mail addresses: [email protected] (A. Chauhan), [email protected] (Y.K. Gupta). 0166-4328/$ – see front matter © 2012 Elsevier B.V. All rights reserved. doi:10.1016/j.bbr.2012.01.005